GHK-Cu 3% + Hyaluronic Acid 2% Solution Pro — Lot 202609GHK_Ser

All lot records
Lot record

GHK-Cu 3% + Hyaluronic Acid 2% Solution – Pro, lot 202609GHK_Ser

A vial from this lot was sent to Hyte Research Division for independent analysis. This page is the record of what came back, published whole and unedited.
Released 30 mg vial Lab No. 202609GHK_Ser
Laboratory
Hyte Research Division
Sample received
29 September 2026
Results reported
8 October 2026
BATCH
VERIFICATION
LOT NUMBER
202609GHK_Ser
30 mg vial
IDENTITY
Conforms to GHK-Cu reference standard
CHROMATOGRAPHIC PURITY
99.89%
CONCENTRATION
29.42 mg/mL (98.1% of 30 mg/mL label claim)
Analytical characterization

Every result against its specification.

Lot 202609GHK_Ser · 30 mg vial · Hyte Research Division · reported 8 October 2026 . The bar shows where the reported result falls against Astramide’s published release criterion. The notch marks the criterion.
Within criterion Above criterion Not on this COA
Test
Method
Criterion
Result
Result vs criterion
Status
Identity
HPLC-DAD
Conforms to reference standard
Conforms to GHK-Cu reference standard
WITHIN SPEC
Chromatographic purity
HPLC-DAD
at or above 99.0%
99.89%
95 at or above 99.0% 100
WITHIN SPEC
Concentration
HPLC-DAD
at least 90% of 30 mg/mL
29.42 mg/mL (98.1% of 30 mg/mL label claim)
80 at least 90% of 30 mg/mL 120
WITHIN SPEC
Hyaluronic acid content
—
Not reported on this certificate
NOT REPORTED
Endotoxin
LAL
—
Not reported on this certificate
NOT REPORTED
Sterility
—
Not reported on this certificate
NOT REPORTED
Heavy metals
—
Not reported on this certificate
NOT REPORTED
Values are reported per vial unless otherwise noted. Every figure here is taken from the batch Certificate of Analysis and nothing else.
Certificate of Analysis
GHK-Cu 3% + Hyaluronic Acid 2% Solution – Pro · Lot 202609GHK_Ser · 30 mg vial · Lab No. 202609GHK_Ser
Download Full screen
Your browser cannot display the report inline. Open the PDF.
Hyte Research Division · 2 pages · served inline, not a screenshot
Quick reference

How to read this report

Same six keys on every Astramide product page. Only the values change.
1Lot numberMatch it to the number printed on your vial. If they differ, this report is not for your vial.
2IdentityMass spectrometry confirms the molecule is the one on the label. It conforms or it does not. There is no partial result.
3Chromatographic purityThe share of the material that is the target peptide. A purity figure quoted without a method is not a purity figure.
4Net contentHow much peptide is in the vial, as measured by the laboratory. A different question from purity.
5EndotoxinMeasured against a ceiling, not a floor. Sensitivity differs by laboratory, so results are not compared across labs.
6Laboratory, method, dateWho ran it, on what instrument, and when. A report with no named laboratory or no date is not a report.

What does this record cover?

One lot, and one lot only: lot 202609GHK_Ser, in the 30 mg vial. Results from one lot do not carry over to the next. Match the lot number printed on your vial to the lot number on this page before you rely on any figure here. If the two differ, this is not the report for your vial.

Who ran the testing?

Hyte Research Division ran the analysis. Astramide does not test its own material and does not report its own numbers. How we test sets out which laboratories we use and what each method measures.

Where is the original document?

The Certificate of Analysis above is the laboratory’s own PDF, served whole and downloadable. It is not a screenshot, a transcription or a summary. Every figure on this page is read from it. Every lot we have tested is published the same way, including the ones we rejected.

Where can this compound be found?

GHK-Cu 3% + Hyaluronic Acid 2% Solution – Pro carries its full batch history, including this lot. Research use only.

Research use only

All products sold by Astramide are intended exclusively for laboratory research purposes. They are not intended for human consumption, medical, therapeutic, or diagnostic use.